{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:04:13Z","timestamp":1758636253287},"reference-count":34,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2006]]},"DOI":"10.1536\/ihj.47.607","type":"journal-article","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T05:52:04Z","timestamp":1157608324000},"page":"607-616","source":"Crossref","is-referenced-by-count":10,"title":["&lt;b&gt;Carvedilol Prevents Myocardial Fibrosis in Hamsters&lt;\/b&gt;"],"prefix":"10.1536","volume":"47","author":[{"given":"Shuji","family":"Nanjo","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Ohmori Hospital. Toho University School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Ohmori Hospital. Toho University School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Radiotechnical Sciences, Faculty of Radiological Health Sciences, Komazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Second Department of Pathology, Toho University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Togane","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Ohmori Hospital. Toho University School of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-36.","DOI":"10.1136\/hrt.37.10.1022"},{"key":"2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","volume":"90","year":"1994","unstructured":"2. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765-73.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Colucci WS, Packer M, Bristow MR, <i>et al<\/i>. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996; 94: 2800-6.","DOI":"10.1161\/01.CIR.94.11.2800"},{"key":"4","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","year":"2002","unstructured":"4. Packer M, Fowler MB, Roecker EB, <i>et al<\/i>. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-9.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nanjo S, Yamazaki J, Yoshikawa K, Miura M, Seno A. Efficacy of contrast-enhanced MR imaging in cardiomyopathy: an experimental study using Bio14.6 hamsters. Acad Radiol 2002; 9: 1139-47.","DOI":"10.1016\/S1076-6332(03)80515-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ruffolo RR Jr, Gellai M, Hieble JP, Willette RN, Nichols AJ. The pharmacology of carvedilol. Eur J Clin Pharmacol 1990; 38: S82-8. (Review)","DOI":"10.1007\/BF01409471"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nichols AJ, Gellai M, Ruffolo RR Jr. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol 1991; 5: 25-38.","DOI":"10.1111\/j.1472-8206.1991.tb00698.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J 1995; 16: 38-42. (Review)","DOI":"10.1093\/eurheartj\/16.suppl_F.38"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Homburger F. Myopathy of hamster dystrophy: history and morphologic aspects. Ann NY Acad Sci 1979; 317: 2-17. (Review)","DOI":"10.1111\/j.1749-6632.1979.tb56503.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bajusz E. Hereditary cardiomyopathy: a new disease model. Am Heart J 1969; 77: 686-96.","DOI":"10.1016\/0002-8703(69)90556-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Strobeck JE, Facter SM, Bhan A, <i>et al<\/i>. Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural features. Ann NY Acad Sci 1979; 317: 59-88.","DOI":"10.1111\/j.1749-6632.1979.tb56511.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Whitmer JT. L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res 1987; 61: 396-408.","DOI":"10.1161\/01.RES.61.3.396"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Whitmer JT, Kumar P, Solaro RJ. Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Circ Res 1988; 62: 81-5.","DOI":"10.1161\/01.RES.62.1.81"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Farmer D, Higgins CB, Yee E, Lipton MJ, Wahr D, Ports T. Tissue characterization by magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 1985; 55: 230-2.","DOI":"10.1016\/0002-9149(85)90339-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zahler R, Chelman D, Gore J. Heterogeneous signal intensity in magnetic resonance images of hypertrophied left ventricular myocardium. Magm Reson Imaging 1989; 7: 517-28.","DOI":"10.1016\/0730-725X(89)90405-0"},{"key":"16","unstructured":"16. Nanjo S, Yamashina S, Yamazaki J. Evaluation of myocardial tissue characterization in dilated cardiomyopathy using MRI Gd-DTPA radiography. J Cardiology 1994; 24 (Suppl): 153. (Japanese)"},{"key":"17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiology.153.1.6473778","volume":"153","year":"1984","unstructured":"17. Wesbey GE, Higgins CB, McNamara MT, <i>et al<\/i>. Effects of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 1984; 153: 165-9.","journal-title":"Radiology","ISSN":"http:\/\/id.crossref.org\/issn\/0033-8419","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. de Roos A, Doornbos J, van der Wall EE, van Voorthuisen AE. MR imaging of acute myocardial infarction: value of Gd-DTPA. AJR 1988; 150: 531-4.","DOI":"10.2214\/ajr.150.3.531"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wu AH, Das SK. Sudden death in dilated cardiomyopathy. Clin Cardiol 1999; 22: 267-72. (Review)","DOI":"10.1002\/clc.4960220404"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cappato R, Negroni S, Bentivegna S, <i>et al<\/i>. Role of implantable cardioverter defibrillators in dilated cardiomyopathy. J Cardiovasc Electrophysiol 2002; 13: S106-9. (Review)","DOI":"10.1111\/j.1540-8167.2002.tb01962.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hano O, Mitsuoka T, Matsumoto Y, <i>et al<\/i>. Arrhythmogenic properties of the ventricular myocardium in cardiomyopathic Syrian hamster, BIO 14.6 strain. Cardiovasc Res 1991; 25: 49-57.","DOI":"10.1093\/cvr\/25.1.49"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Packer M, Coats AJ, Fowler MB, <i>et al<\/i>; Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8.","DOI":"10.1056\/NEJM200105313442201"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Homburger F. Myopathy of hamster dystrophy: history and morphologic aspects. Ann NY Acad Sci 1979; 317: 1-17. (Review)","DOI":"10.1111\/j.1749-6632.1979.tb37318.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bajusz E. Hereditary cardiomyopathy: a new disease model. Am Heart J 1969; 77: 686-96. (Review)","DOI":"10.1016\/0002-8703(69)90556-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Strobeck JE, Factor SM, Bhan A, <i>et al<\/i>. Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical and structural features. Ann NY Acad Sci 1979; 317: 59-88.","DOI":"10.1111\/j.1749-6632.1979.tb56511.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sia YT, Parker TG, Tsoporis JN, Liu P, Adam A, Rouleau JL. Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat. J Cardiovasc Pharmacol 2002; 39: 73-87.","DOI":"10.1097\/00005344-200201000-00009"},{"key":"27","unstructured":"27. Aso H. Evaluation of fibrosis in cardiomyopathy by Gd-DTPA contrast-enhanced magnetic resonance imaging: study of cardiomyopathic BIO14.6 hamsters. Mie Igaku 1995; 39: 65-74. (Japanese)"},{"key":"28","unstructured":"28. Munakata T. Histopathological significance of MRI enhancement effects in cardiomyopathic (BIO14.6) hamsters. JMRM 1998; 18: 286-97. (Japanese)"},{"key":"29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.153.1.6433402","volume":"153","year":"1984","unstructured":"29. Runge VW, Clanton JA, Herzer WA, <i>et al<\/i>. Intravascular contrast agents suitable for magnetic resonance imaging. Radiology 1984; 153: 171-6.","journal-title":"Radiology","ISSN":"http:\/\/id.crossref.org\/issn\/0033-8419","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Brash RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR 1984; 142: 625-30.","DOI":"10.2214\/ajr.142.3.625"},{"key":"31","unstructured":"31. Robbin SL, Cotran RS, Kumar VP. <i>Pathologic Basis of Disease<\/i>. Philadelphia, PA, USA: W.B. Saunders; 1984; 40-68."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lotze U, Heinke S, Fritzenwanger M, Krack A, Muller S, Figulla HR. Carvedilol inhibits platelet-derived growth factor-induced signal transduction in human cardiac fibroblasts. J Cardiovasc Pharmacol 2002; 39: 576-89.","DOI":"10.1097\/00005344-200204000-00014"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Barone FC, Campbell WG Jr, Nelson AH, Feuerstein GZ. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling. J Hypertens 1998; 16: 871-84.","DOI":"10.1097\/00004872-199816060-00019"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104: 2838-42.","DOI":"10.1161\/hc4801.100351"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/47\/4\/47_4_607\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T02:17:04Z","timestamp":1555813024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/47\/4\/47_4_607\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.47.607","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}